Clinical trial

Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung…

NCT00022308 · Fox Chase Cancer Center, Other · Completed

Key facts

NCT number NCT00022308
Title Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Official title Phase I Trial of Radical Thoracic Radiation, Weekly CPT-11 (Irinotecan) and Cisplatin in Locally Advanced Non-Small Cell Lung Carcinoma
Lead sponsor Fox Chase Cancer Center, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Lung Cancer
Intervention type Drug, Radiation
Interventions cisplatin, irinotecan hydrochloride, radiation therapy
Start date Jan 1, 1999
Primary completion Sep 1, 2006
Completion Sep 1, 2006
First posted Feb 27, 2004
Last update posted Sep 2, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies